RBM24 and cancer: These works identify a critical role of the eIF4E-binding motif to modulate RBM24/RBM38 activity in cancer cells and raise the possibility that disrupting RBM24/RBM38-eIF4E complex may represent a potential therapeutic approach for cancer treatment.